Intravitreal Bevacizumab for Choroidal Neovascularization and Cystoid Macular Edema: A Cost-Effective Treatment?
Author:
Publisher
SLACK, Inc.
Subject
Ophthalmology,Surgery
Reference6 articles.
1. 1. Rosenfeld PJ Moshfeghi AA Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular agerelated macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:331-335.
2. 2. Rosenfeld PJ Fung AE Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336-339.
3. 3. Gragoudas ES Adamis AP Cunningham ET Jr Feinsod M Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl f Med. 2004;35 1:28052816.
4. 4. Hurwitz H Fehrenbacher L Novotny W et al. Bevacizumab plus irinotecan fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.
5. 5. Michels S Rosenfeld PJ Puliafito CA Marcus EN Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study. Ophthalmology. 2005;1 12:1035-1047.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The 100 top-cited articles in macular edema from 1950 to 2020;Seminars in Ophthalmology;2021-07-23
2. Ranibizumab (Lucentis): a New Anti-Angiogenic Treatment in Ophthalmology;Handbook of Therapeutic Antibodies;2014-08-12
3. INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF SUBRETINAL FLUID ASSOCIATED WITH CHOROIDAL OSTEOMA;Retina;2010-06
4. Identifying Early Recurrence of Choroidal Neovascularization during Treatment with Ranibizumab using C-Scan;European Journal of Ophthalmology;2010-05
5. Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome;Korean Journal of Ophthalmology;2009
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3